VIVEbiotech accelerates therapy development with unbeatable timelines
Full integration, specialization, and operational efficiency as key drivers to accelerate innovative therapies without compromising quality.
In the biotechnology sector, time is a critical factor for the successful development of new therapies. At VIVEbiotech, we are fully aware of this demand and have designed a comprehensive operational model that allows us to respond with efficiency and rigor to the industry’s needs.
Our plug-and-play platform specialized in lentiviral vectors, combined with a highly qualified multidisciplinary team and the full integration of all process stages — from development to manufacturing and quality control — enables us to optimize workflows and significantly reduce development timelines without compromising the highest quality standards.
In this brief video, Ana Valero, PhD, Head of Technology Transfer, explains the factors that make our development timelines unbeatable, positioning VIVEbiotech as a strategic partner to accelerate innovative therapies to patients.
🔗 You can watch the full video on our YouTube channel or on our LinkedIn page.